{
    "url_original": "https://www.wsj.com/articles/chinese-telemedicine-stocks-feel-the-pain-as-tougher-rules-loom-11639477805?mod=markets_lead_pos4",
    "url": "chinese-telemedicine-stocks-feel-the-pain-as-tougher-rules-loom-11639477805",
    "title": "Chinese Telemedicine Stocks Feel the Pain as Tougher Rules Loom",
    "sub_head": "Increased regulatory scrutiny and impending changes have taken the wind out of the country’s once-highflying shares",
    "category_1": "Markets",
    "time": "2021-12-14 05:30:00",
    "body": "Companies that operate telemedicine platforms have been among the biggest beneficiaries of the coronavirus pandemic, thanks to a surge in demand from people seeking online medical advice and drug prescriptions.<br />In China, however, increased regulatory scrutiny and impending rule changes for the internet healthcare industry have taken the wind out of the sector’s once-highflying stocks."
}